Tag: drug exclusivity
2
FebruaryPediatric Exclusivity: How the FDA Extends Market Protection Without Changing Patents
Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested pediatric studies. It doesn't extend patents but blocks generic approvals, creating a powerful regulatory tool that improves children's drug safety.
Recent posts
-
16 Oct 2025
Prednisolone (Omnacortil) vs. Common Alternatives: A Practical Comparison
-
27 Oct 2025
Compare Ranol SR (Propranolol) with Alternatives: What Works Best for You
-
6 Dec 2025
Blood Pressure Targets: 120/80 vs. Individualized Goals for Better Heart Health
-
30 Apr 2026
HIV Medications and Statins: Safe Combinations and Avoiding Side Effects
-
16 May 2026
Stability and Shelf Life: Understanding Generic Degradation and Safety Protocols